When the International AIDS Society 2015 Conference on HIV Pathogenesis, Treatment & Prevention convenes in Vancouver, British Columbia Sunday, Science Speaks will be there, bringing live coverage of breaking news and reporting on presentations from leading clinicians and researchers. Stay tuned July 19 – 22 for updates on the START trial, HPTN 052, optimizing treatment, […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
With a report showing that 2018 yielded the highest case numbers seen so far of a paralyzing condition largely among children who had been sick with […]